Exhibit 10.2


 


AMENDMENT NO.1 TO 


CONSULTING AGREEMENT


 


This Amendment No. 1
to Consulting Agreement (“Amendment”) is entered into by and between Outlook Therapeutics, Inc. (“Company”)
and The Dagnon Group LLC (such entity, including its control persons, affiliates, directors and officers, “Consultant”)
(each herein referred to individually as a “Party,” or collectively as the “Parties”)
as of November 1, 2021 (“Effective Date”).


 


Company and Consultant entered
into that certain Consulting Agreement as of January 27, 2020 (the “Consulting Agreement”), and Company
and Consultant desire to amend Exhibit A of the Consulting Agreement pursuant to the terms of this Amendment. In consideration of
Consultant’s continued engagement with the Company and other good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, and intending to be legally bound, the Parties agree as follows:


 


1.              Definitions


 


Capitalized terms used herein
and not otherwise defined shall have the same meaning as set forth in the Consulting Agreement.


 


2.              Amendments


 


The Parties hereby agree that
the Consulting Agreement shall be amended as follows:


 


In Section 2 of Exhibit A of
the Consulting Agreement, reference to “20 hours” shall be struck and replaced with “30 hours” so that the relevant
portion of Section 2 of Exhibit A of the Consulting Agreement shall read as follows:


 


“The Company and Consultant agree
that the Services: (A) will require up to 30 hours of work by Consultant per week for the Company, provided that Consultant may provide
more than 30 hours of work upon mutual agreement of the Parties . . . .”


 


The Services Fee in Section 3.A of
Exhibit A of the Consulting Agreement shall be increased from a monthly fee of $25,000 to a monthly fee of $37,500 for performing
the Services during the term of the Consulting Agreement.


 


3.              Continuation


 


Except as set forth herein,
all of the terms and conditions set forth in the Consulting Agreement, including its exhibits, are unchanged and shall remain in full
force and effect and are hereby ratified and confirmed by the Parties hereto. If any provision of this Amendment is inconsistent with
the Consulting Agreement, the Parties intend that the terms of this Amendment shall control solely to the extent required to make the
Consulting Agreement consistent with this Amendment.


 


4.              Construction
of Terms


 


This Amendment constitutes
the entire understanding between the Parties with respect to the subject matter hereof, and supersedes any other agreements or promises
made to Consultant by anyone with respect to this subject matter, whether oral or written. No modification to this Amendment shall be
valid unless in writing and signed by the Parties hereto.


 


5.              Governing
Law


 


This Agreement shall be governed
by the laws of the State of Delaware, without regard to the conflicts of law provisions of any jurisdiction.


 






    1


     


    

 


6.              Counterparts


 


This Amendment may be executed
in one or more counterparts, each of which shall be deemed to be an original, with the same force and effectiveness as though executed
in a single document.


 


7.              Effective
Date


 


The terms and conditions set
forth in this Amendment shall be effective as of the Effective Date.


 


IN WITNESS WHEREOF, the Parties
hereto have executed this Amendment as of November 8, 2021.


 


	THE DAGNON GROUP, LLC	 	Outlook
Therapeutics, Inc.
	 	 	 
	By:	/s/ Terry J. Dagnon	 	By:	/s/ C. Russell Trenary III
	 	 	 	 
	Name: 	Terry J. Dagnon	 	Name: 	/s/ C. Russell Trenary III
	 	 	 	 
	Title: 	President	 	Title: 	President and Chief Executive Officer



 






    2